Report - Tratamiento antiretroviral(TAR) · Ausencia de beneficio de inicio precoz del TAR Conclusions: There was no clear immunological or virologicaladvantage in starting HAART at a CD4

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form